NCT03501979 2025-08-29Tucatinib, Trastuzumab, and Capecitabine for the Treatment of HER2+ LMDUniversity of Alabama at BirminghamPhase 2 Terminated17 enrolled 16 charts
NCT01596127 2018-05-24Intrathecal Rituximab in Lymphoid Malignancies Involving Central Nervous SystemM.D. Anderson Cancer CenterPhase 1/2 Terminated4 enrolled 7 charts